Table 5 Comparison of gene alterations between benign and malignant cases. (Added cases from literature)
Gene fusion type | UTROSCT (n = 31) | ||
|---|---|---|---|
Benign behavior (n = 20) | Malignant behavior (n = 11) | ||
the 3’ partners (*P<0.05) | NCOA1 Fusion | 3 (15.0%) | 0(0.0%) |
NCOA2 Fusion | 2 (10.0%) | 8(72.7%) | |
NCOA3 Fusion | 11(55.0%) | 0(0.0%) | |
Others | 4 (20.0%) | 3(27.3%) | |
the 5’ partners (P > 0.05) | ESR1 Fusion | 12 (60.0%) | 5(45.4%) |
GREB1 Fusion | 4 (20.0%) | 3(27.3%) | |
Others | 4 (20.0%) | 3(27.3%) | |